Anne-marie Duliege - Net Worth and Insider Trading

Anne-marie Duliege Net Worth

The estimated net worth of Anne-marie Duliege is at least $0 dollars as of 2024-11-11. Anne-marie Duliege is the EVP & Chief Medical Officer of Rigel Pharmaceuticals Inc and owns about 0 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $0. Details can be seen in Anne-marie Duliege's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anne-marie Duliege has not made any transactions after 2018-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anne-marie Duliege

To

Anne-marie Duliege Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anne-marie Duliege owns 3 companies in total, including Rigel Pharmaceuticals Inc (RIGL) , ChemoCentryx Inc (CCXI) , and Affymax Inc (AFFY) .

Click here to see the complete history of Anne-marie Duliege’s form 4 insider trades.

Insider Ownership Summary of Anne-marie Duliege

Ticker Comapny Transaction Date Type of Owner
RIGL Rigel Pharmaceuticals Inc 2018-09-17 Chief Medical Officer
CCXI ChemoCentryx Inc 2014-03-25 EVP & Chief of Strategic Dev.
AFFY Affymax Inc 2013-01-30 Chief Medical Officer

Anne-marie Duliege Latest Holdings Summary

Anne-marie Duliege currently owns a total of 1 stock. Anne-marie Duliege owns 0 shares of Rigel Pharmaceuticals Inc (RIGL) as of September 17, 2018, with a value of $0.

Latest Holdings of Anne-marie Duliege

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2018-09-17 0 21.93 0

Holding Weightings of Anne-marie Duliege


Anne-marie Duliege Form 4 Trading Tracker

According to the SEC Form 4 filings, Anne-marie Duliege has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 15,300 shares on September 17, 2018, which brought Anne-marie Duliege around $535,500.

Insider Trading History of Anne-marie Duliege

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anne-marie Duliege Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anne-marie Duliege Ownership Network

Ownership Network List of Anne-marie Duliege

No Data

Ownership Network Relation of Anne-marie Duliege

Insider Network Chart

Anne-marie Duliege Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Anne-marie Duliege is the Chief Medical Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Commercial Officer David A Santos , EVP & Chief Financial Officer Dean L Schorno , and Sr VP of Bus Dev and Com Ops Raul R Rodriguez .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Anne-marie Duliege made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

Anne-marie Duliege Mailing Address

Above is the net worth, insider trading, and ownership report for Anne-marie Duliege. You might contact Anne-marie Duliege via mailing address: 4001 Miranda Avenue, Palo Alto Ca 94304.